Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope. - Wikidata - wikimedia - TriplyDB

Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope.

Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope.

http://www.wikidata.org/entity/Q45748463

about

Amplification of autoimmune disease by infection The challenge of early synovitis: multiple pathways to a common clinical syndrome The Autoimmune Ecology Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and rheumatoid arthritis Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation How Rheumatoid Arthritis Can Result from Provocation of the Immune System by Microorganisms and Viruses The immunology of Epstein-Barr virus infection Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease.Epstein-Barr virus and rheumatoid arthritis: is there a link?Effect of anti-rheumatic agents on periodontal parameters and biomarkers of inflammation: a systematic review and meta-analysis.Should infection still be considered as the most likely triggering factor for rheumatoid arthritis?A profile of immune response to herpesvirus is associated with radiographic joint damage in rheumatoid arthritis.Epstein-Barr virus serologic abnormalities and risk of rheumatoid arthritis among women Detection of Epstein-Barr virus in synovial fluid of rheumatoid arthritis patients Antibodies directed against endogenous and exogenous citrullinated antigens pre-date the onset of rheumatoid arthritis Toll/Interleukin-1 Receptor Domain Derived from TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis by Down-modulating Th17 Cell Response.Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.Epstein-Barr virus in systemic autoimmune diseases Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor.Epstein-Barr-Virus-Infected CD15 (Lewis X)-Positive Hodgkin-Lymphoma-Like B Cells in Patients with Rheumatoid Arthritis.A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA.IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients.HLA-DRB1 the notorious gene in the mosaic of autoimmunity.Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis.Co-existence of acute myeloid leukemia with multilineage dysplasia and Epstein-Barr virus-associated T-cell lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report.Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology.Monoclonal antibody against citrullinated peptides obtained from rheumatoid arthritis patients reacts with numerous citrullinated microbial and food proteins.Epstein-Barr virus infection transforms CD25+ B cells into antibody-secreting cells in rheumatoid arthritis patients.Rheumatoid arthritis and Epstein-Barr virus: a case of living with the enemy?Epstein-Barr virus associated diffuse large B-cell lymphoma complicated by autoimmune hemolytic anemia and pure red cell aplasia.Hyaluronan production in synoviocytes as a consequence of viral infections: HAS1 activation by Epstein-Barr virus and synthetic double- and single-stranded viral RNA analogs.Decreased expression of signaling lymphocytic-activation molecule-associated protein (SAP) transcripts in T cells from patients with rheumatoid arthritis.Role of HTLV-I infection in the pathogenesis of Sjögren's syndrome and rheumatoid arthritis.

P2860

Q24804390-D7A7B7C3-FE74-45B1-A6B1-C87A4F4041A3 Q24805007-F573D44D-8F52-4D38-AF28-135F7D5B8B93 Q26747427-CB897D6E-3C8A-4F1F-9B4D-DB2E02F57BCF Q26785341-93D31347-0EB7-4578-9368-1CD4E2251035 Q26830464-0E9E57B6-8A05-4C03-A7FE-4DDD396AE100 Q27468876-5C68E4B9-7368-4961-914D-AB267EC5BA93 Q34225567-7BA12948-CF2C-495A-87DA-EB72B044D9DD Q34275907-50ED30B8-8D5E-4D6F-8F49-00DF32DCC5C9 Q34896078-B5E533D4-EF1A-46F5-9B31-715E990A4F30 Q35813073-B26B6A86-6186-4AD7-8C71-A27C2EEEC931 Q35915966-FE8B7AB6-6623-4884-B19C-D295B0F1A13F Q36084979-ECAACB6D-EEB9-427D-BBAB-9A0A66469CB3 Q36543431-0B15D486-C595-41EF-97ED-3E0EC7A6CB53 Q36834066-D7A5E1D8-5DB3-4963-9063-355A323A2400 Q36965739-55C553D9-B295-47D0-8952-D3AF16564DF6 Q37066063-D4248FC7-8A05-4491-8BEC-BDF663B33221 Q37146126-F8BD7F35-AC58-49AF-8218-6530267EF169 Q37154847-0C32E4A8-E005-45B6-BC2E-5288CD03AC5A Q37272142-CEC054D9-2582-420F-BF17-129F08C97505 Q37350444-F20FC669-031E-467D-9946-7E6F63CF78B7 Q37480830-7B361808-5584-4496-B94D-F6DA0AFB6A57 Q37690200-2BDABB24-4E88-4CC6-8CFC-ADF33F13B4B8 Q40607323-F5DB10B9-08DB-4AD4-9517-285C76C0956A Q40974392-9E56D5B4-7363-4A17-BC8B-1B76990D74DA Q41858036-81B43122-250B-4CD6-A21E-281CC50EFFF3 Q41927788-EBC81FEA-3BB4-449F-99F6-0A844E31B0AE Q42147081-B633FFF4-41AC-42AE-8D8C-0B0B8BD950EC Q42284576-8FE2EC17-65AA-468C-BB91-1722B46704CC Q43052621-37DCAB78-8844-489A-BF9B-174B71219162 Q43792840-CA37E678-D19E-4875-BB43-8CF7C263BE03 Q45395915-A01647B5-A66D-4995-BE82-D4E553B003A4 Q48372468-C66AB41D-B431-493B-B239-6335C6691687 Q55239807-79ADBBE6-4F7A-4E59-A466-9D6606CCA873

P2860

Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope.

http://www.wikidata.org/entity/Q45748463

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh-hant

name

Synovial Epstein-Barr virus in ...... th the shared HLA-DR4 epitope.

@en

Synovial Epstein-Barr virus in ...... th the shared HLA-DR4 epitope.

@nl

type

label

Synovial Epstein-Barr virus in ...... th the shared HLA-DR4 epitope.

@en

Synovial Epstein-Barr virus in ...... th the shared HLA-DR4 epitope.

@nl

prefLabel

Synovial Epstein-Barr virus in ...... th the shared HLA-DR4 epitope.

@en

Synovial Epstein-Barr virus in ...... th the shared HLA-DR4 epitope.

@nl

P1433

Q45748463-01E25FF8-8E4C-4E92-A369-3A4D6F2EED44

P1476

Q45748463-F0F2941B-55EC-4086-BCD4-C10D4433F977

P2093

Q45748463-01C750C3-B5E1-4429-A044-2384DC2E10DC

Q45748463-07D8582B-E185-4786-A6CF-1012CD7F1C36

Q45748463-0B469BFF-4615-44E8-A626-F4835C103D1D

Q45748463-15901AA1-18CA-4CF0-AF9E-0F6D5A9094BE

Q45748463-24B346B1-024B-44A7-BED4-1B38665931D6

Q45748463-2CC984C9-C99B-41A9-A441-E29D5B5E60C0

Q45748463-4AB58770-9A6B-4E93-8921-76DCF20D20F1

Q45748463-8DF33CC0-CCA9-440D-AA88-8B5CE4653B57

Q45748463-B5953627-1179-430C-9775-18DC26CF2338

Q45748463-D244C495-936A-4B4E-8915-9356B43BDF5A

P2860

Q45748463-0ED56EE3-F64E-4E2F-A4B8-F28DA1DFB556

Q45748463-145F4154-1BCF-4306-AA55-D72F572A4143

Q45748463-1D6D335A-A5C3-4037-B8C1-D7917CCACD24

Q45748463-21E1AD65-71DB-4969-BAB8-135A83E6C5AC

Q45748463-28892CFC-BCA3-4687-AF45-CCB94E08E557

Q45748463-2A1B8629-2B2C-438D-ABD6-065F5F0D4731

Q45748463-3B130E82-3BC5-4430-A6F9-B66FA7A0EFB3

Q45748463-3C4BA211-EE08-43AF-A19C-62E4CE9E7231

Q45748463-45967B00-B0E8-4454-B031-2A05A9378309

Q45748463-5143E441-A9B7-4033-B884-81C2C8338257

P304

Q45748463-EFB9575F-2421-4D12-B749-72C4A77668C9

P31

Q45748463-70F6898B-68B9-4855-9A0F-5B85C8F97A73

P356

Q45748463-46E730F9-C8AC-4815-B5A1-EC007158E91F

P433

Q45748463-4E28A874-DC2E-4837-8BDD-A6581E325363

P478

Q45748463-770B7C42-2F92-4EF4-A960-DB8DCDE6686C

P577

Q45748463-5B281C87-9758-4488-B854-0F213A16D14C

P698

Q45748463-FECDE4A8-FCA1-4B49-A293-F31799A03A8C

P921

Q45748463-3CF25434-F8C9-4E4A-9E23-14891B3DB35F

P356

1529-0131(199907)42:7%3C1485::AID-ANR24%3E3.0.CO;2-7

P1433

Arthritis & Rheumatology

P1476

Synovial Epstein-Barr virus in ...... th the shared HLA-DR4 epitope.

@en

P2093

Einsele H

http://www.w3.org/2001/XMLSchema#string

Fritz P

http://www.w3.org/2001/XMLSchema#string

Gerneth F

http://www.w3.org/2001/XMLSchema#string

Koch S

http://www.w3.org/2001/XMLSchema#string

Krimmel M

http://www.w3.org/2001/XMLSchema#string

Müller CA

http://www.w3.org/2001/XMLSchema#string

Saal JG

http://www.w3.org/2001/XMLSchema#string

Sell S

http://www.w3.org/2001/XMLSchema#string

Steidle M

http://www.w3.org/2001/XMLSchema#string

Wagner S

http://www.w3.org/2001/XMLSchema#string

P2860

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Correlation between disease phenotype and genetic heterogeneity in rheumatoid arthritis.

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

Susceptibility to rheumatoid arthritis maps to a T-cell epitope shared by the HLA-Dw4 DR beta-1 chain and the Epstein-Barr virus glycoprotein gp110.

Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis

Human parvovirus B19 as a causative agent for rheumatoid arthritis.

Analysis of the defects responsible for the impaired regulation of Epstein-Barr virus-induced B cell proliferation by rheumatoid arthritis lymphocytes. I. Diminished gamma interferon production in response to autologous stimulation.

T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis.

Perturbation of the T cell repertoire in rheumatoid arthritis.

P304

1485-1496

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1529-0131(199907)42:7<1485::AID-ANR24>3.0.CO;2-7

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

1999-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10403278

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus